Premium
Pandemics vs. Cancer Smouldering Epidemics
Author(s) -
Markovic Olivera,
Markovic Nenad
Publication year - 2021
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2021.35.s1.04743
Preparing this abstract for Experimental Biology Meeting, we were attracted with a possible comparison between a dark clouds coming over everlasting smoldering cancer epidemics on the earth. Indeed, COVID‐19 came unexpected, like a cloud hiding the sunshine, with rain pouring with hail and snow, with lightning and thunder attracted full attention of affected human societies on the earth and caused panicking responses which resulted in additional harm to living subjects and habitats in its shadow. In our long professional life, we met several pandemics including the smallpox, cholera and whooping cough. Influenza, HIV and ebola were recent. The experience said that all of them are temporary, they a coming and passing, but leaving the consequences. Among them is the increased number of death by chronic diseases including cancer patients. We learned that daring pandemics our attention to the existing smoldering cancer epidemics should never be decreased, but always increased and the preventive measures be strengthened. Our help had to provide protection against panic (umbrella against the cloud) and urge for encouragement to strengthen the prevention. As the knowledge is the strongest tool against fear, we first look as the pandemic data worldwide and we found the corona virus is highly contagious, but with limited pathogenic affect (15‐20% infections) and very little mortality (1‐2% of infected. (Data referred to CNN on 1/7/2‐21) In the other field, we turn to the cervical cancer which is a subject of our recent studies. In 2017, we published a book, What Every Women Should Know About Cervical Cancer (Springer Science, 2017) where we promoted a new strategy to fight cervical cancer globally (more than 60% outreach among women at risk, in comparison with current rate of 20% worldwide)/ This experimentally confirmed strategy is to return the cancer mortality curves from up to downtrend and to sustain this trend by more applicable products and services. (Experimentally proven in the USA). The strategy, the products and services are now included into a USPTO application “MarkPap System) which is pending for issuance to become easy applicable worldwide. It is expected (experimentally conformed) that, if this system is applied on more than 52% of women at risk in any society, the negative mortality trends will be reversed, and the fatal prognosis of cervical cancer can be reversed. The purpose of this article is to remind our colleagues to already present opportunities to fight their enemies and not to be frightened by the COVID‐19 which will pass. Prevent consequences of COVID ‐19 on cancer patients is the conditio sine qua non good medicine.